We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+1.71%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$4.94B
AUM Growth
+$247M
Cap. Flow
+$219M
Cap. Flow %
4.43%
Top 10 Hldgs %
54.49%
Holding
66
New
9
Increased
26
Reduced
20
Closed
6

Top Buys

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$166M
2
CI icon
Cigna
CI
+$114M
3
USFD icon
US Foods
USFD
+$102M
4
DXC icon
DXC Technology
DXC
+$84.5M
5
APTV icon
Aptiv
APTV
+$74.6M

Top Sells

Rank Stock Value
1
MCK icon
McKesson
MCK
+$164M
2
WTW icon
Willis Towers Watson
WTW
+$86.2M
3
BHC icon
Bausch Health
BHC
+$79.3M
4
THC icon
Tenet Healthcare
THC
+$77.7M
5
FMC icon
FMC
FMC
+$48.9M

Sector Composition

Rank Sector Weight
1 Healthcare 48.81%
2 Technology 16.28%
3 Consumer Discretionary 10.31%
4 Industrials 9.41%
5 Materials 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
1
Tenet Healthcare
THC
$20.1B
$549M 11.11%
6,381,043
-946,065
-13% -$77.7M
CI icon
2
Cigna
CI
$76.1B
$382M 7.74%
1,595,997
+486,463
+44% +$114M
GPN icon
3
Global Payments
GPN
$22B
$322M 6.53%
2,356,312
+268,655
+13% +$37.5M
MCK icon
4
McKesson
MCK
$97.9B
$287M 5.8%
936,041
-603,811
-39% -$164M
DXC icon
5
DXC Technology
DXC
$1.63B
$246M 4.99%
7,549,011
+2,555,053
+51% +$84.5M
FISV
6
Fiserv Inc
FISV
$27.3B
$217M 4.4%
2,142,801
+1,643,595
+329% +$166M
BHC icon
7
Bausch Health
BHC
$1.66B
$212M 4.28%
9,256,661
-3,245,486
-26% -$79.3M
BAX icon
8
Baxter International
BAX
$11.6B
$171M 3.47%
2,211,036
+28,614
+1% +$2.4M
USFD icon
9
US Foods
USFD
$21.4B
$166M 3.37%
4,419,867
+2,800,755
+173% +$102M
CCEP icon
10
Coca-Cola Europacific Partners
CCEP
$46.5B
$138M 2.8%
2,846,196
+176,509
+7% +$9.46M
UBER icon
11
Uber
UBER
$141B
$137M 2.77%
3,836,585
+1,306,415
+52% +$47M
AMZN icon
12
Amazon
AMZN
$2.51T
$134M 2.7%
819,240
+431,740
+111% +$66.7M
APTV icon
13
Aptiv
APTV
$12B
$132M 2.67%
1,100,186
+560,869
+104% +$74.6M
MTOR
14
DELISTED
MERITOR, Inc.
MTOR
$126M 2.55%
3,544,333
+816,991
+30% +$24.1M
COR icon
15
Cencora
COR
$60B
$116M 2.36%
752,648
-279,640
-27% -$39.6M
DD icon
16
DuPont de Nemours
DD
$18.6B
$114M 2.3%
1,229,657
+27,780
+2% +$2.71M
CNC icon
17
Centene
CNC
$31.2B
$92.1M 1.86%
1,093,420
-263,316
-19% -$21.6M
EHC icon
18
Encompass Health
EHC
$11.2B
$91.4M 1.85%
1,615,916
+680,962
+73% +$35.6M
UHS icon
19
Universal Health Services
UHS
$9.44B
$89.7M 1.82%
618,871
-157,747
-20% -$21.8M
BKD icon
20
Brookdale Senior Living
BKD
$3.64B
$88.7M 1.8%
12,586,280
+2,374,631
+23% +$14.5M
CTVA icon
21
Corteva
CTVA
$59.5B
$87.9M 1.78%
1,529,180
-751,382
-33% -$38.4M
HCA icon
22
HCA Healthcare
HCA
$84.3B
$79.4M 1.61%
316,829
-162,451
-34% -$40.8M
ESI icon
23
Element Solutions
ESI
$9.23B
$67.2M 1.36%
3,066,904
+723,303
+31% +$16.7M
BSX icon
24
Boston Scientific
BSX
$65.9B
$61.3M 1.24%
1,384,629
+285,945
+26% +$12.4M
CHNG
25
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$56.3M 1.14%
2,584,815
+354,004
+16% +$7.35M
1
2 3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

Glenview Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Glenview Capital Management held 66 positions worth $4.94B, up 5.3% from $4.69B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Glenview Capital Management deployed $219M of net new capital in Q1 2022, opening 9 new positions and adding to 26 existing holdings. Its largest new stake was Valvoline: 1,744,570 shares worth $55.1M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 58% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was McKesson, an estimated $164M trimmed.

  • Glenview Capital Management's largest Q1 2022 buy was Valvoline: 1,744,570 shares worth $55.1M.
  • Glenview Capital Management added most to Fiserv Inc in Q1 2022, an estimated $166M increase.
  • Glenview Capital Management's biggest Q1 2022 reduction was McKesson, cutting an estimated $164M.
  • Glenview Capital Management fully exited Willis Towers Watson in Q1 2022, selling an estimated $86.2M.
  • Glenview Capital Management's ten largest holdings make up 54% of its $4.94B portfolio in Q1 2022.
  • Glenview Capital Management opened 9 new positions and closed 6 in Q1 2022.
  • Glenview Capital Management's portfolio value rose 5.3% quarter-over-quarter to $4.94B.

Based on Glenview Capital Management's 13F filing for Q1 2022, filed 16 May 2022.